Home 
HOME Bratislava Medical Journal 2020 Bratislava Medical Journal Vol.121, No.2, p.154–158,2020
HOME Bratislava Medical Journal 2020 Bratislava Medical Journal Vol.121, No.2, p.154–158,2020
Journal info
|
||||
Select Journal
Journals
Bratislava Medical Journal 2024 Ahead of print 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 Endocrine Regulations General Physiology and Biophysics Neoplasma Acta Virologica Studia Psychologica Cardiology Letters Psychológia a patopsych. dieťaťa Kovove Materialy-Metallic Materials Slovenská hudbaWebshop Cart
Your Cart is currently empty.
Info: Your browser does not accept cookies. To put products into your cart and purchase them you need to enable cookies.
Bratislava Medical Journal Vol.121, No.2, p.154–158,2020 |
||
| Title: Coenzyme Q10 improves the survival and reduces inflammatory markers in septic patients | ||
| Author: R. Soltani, B. Alikiaie, F. Shafiee, H. Amiri, S. Mousavi | ||
| Abstract: OBJECTIVE: This study aimed to evaluate the effect of Coenzyme Q10 (CoQ10) administration to patients in the early phase of sepsis to determine its effect on the markers of inflammation and the clinical outcomes of septic patients. BACKGROUND: Previous studies showed that CoQ10 levels were decreased in septic patients and worsening of mitochondrial dysfunction was observed. METHODS: In this randomized controlled trial septic patients (n=40) received 100 mg CoQ10 twice a day for seven days added to standard treatment of sepsis. As a primary endpoint levels of Interleukin 6 (IL-6), Tumor Necrosis Factor-α (TNF-α), Glutathione peroxidase and malondialdehyde (MDA) were assessed at baseline, third and 7th day after the intervention. Secondary endpoints included assessment of clinical scores and in-hospital mortality. RESULTS: There was no difference in baseline inflammatory and oxidative injury markers between the groups. TNF-α and MDA levels decreased significantly in the CoQ10 group on the 7th day of the study (P:0.003 for both). There was a significant difference in the in-hospital mortality in the CoQ10 group compared to the control group (P:0.01). CONCLUSION: These findings suggest that CoQ10 has a positive effect on clinical parameters as well as mitochondrial dysfunction when administered in the early phase of sepsis (Tab. 2, Fig. 1, Ref. 38). |
||
| Keywords: coenzyme Q10, sepsis, mitochondria, antioxidants | ||
| Published online: 23-Jan-2020 | ||
| Year: 2020, Volume: 121, Issue: 2 | Page From: 154, Page To: 158 | |
| doi:10.4149/BLL_2020_022 |
||
|
|
 download file |
|